A Prospective Cohort Study on Cardiotoxicity of Adjuvant Trastuzumab Therapy in Breast Cancer Patients

A Prospective Cohort Study on Cardiotoxicity of Adjuvant Trastuzumab Therapy in Breast Cancer Patients

Abstract Background: Cardiotoxicity is an important side effect of trastuzumab therapy and cardiac surveillance is recommended. Objectives: The aim of our study was to prospectively assess baseline patients' characteristics, level of N-terminal pro-brain natriuretic peptide (NT-proBNP) and ec...

Full description

Bibliographic Details
Main Authors:	Erika Matos, Borut Jug, Rok Blagus, Branko Zakotnik
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Cardiologia (SBC) 2016-01-01
Series:	Arquivos Brasileiros de Cardiologia
Subjects:	Trastuzumab / efeitos adversos Trastuzumab / uso terapêutico Neoplasias da Mama / terapia Cardiotoxicidade Estudos de Coortes
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2016005016102&lng=en&tlng=en

Similar Items

Efeitos adversos do uso de trastuzumabe para tratamento do câncer de mama: uma revisão
by: Roberta Borges Uggeri, et al.
Published: (2014-04-01)

A Importância do Monitoramento e da Identificação Precoce de Cardiotoxicidade do Tratamento com Trastuzumabe no Câncer de Mama: Relato de Caso
by: Patricia Marques Soares Valente, et al.
Published: (2019-12-01)

Is dyslipidemia a risk factor for trastuzumab-induced cardiotoxicity in breast cancer patients? A systematic review and meta-analysis
by: Jaime Pinho, et al.
Published: (2023-12-01)

Enalapril más Carvedilol en la prevención de la cardiotoxicidad por antraciclinas y/o trastuzumab
by: Daysi Luperon Loforte, et al.
Published: (2020-07-01)

Cardiotoxicidade nas Terapias Neoadjuvante e Adjuvante do Câncer de Mama
by: Livia Christina de Oliveira Pina, et al.
Published: (2019-11-01)

Global Longitudinal Strain Accuracy for Cardiotoxicity Prediction in a Cohort of Breast Cancer Patients During Anthracycline and/or Trastuzumab Treatment
by: Eliza de Almeida Gripp, et al.

Early cardiotoxicity after adjuvant concomitant treatment with radiotherapy and trastuzumab in patients with breast cancer
by: Marinko Tanja, et al.
Published: (2018-02-01)

Effectiveness of adjuvant trastuzumab in daily clinical practice
by: Matos Erika, et al.
Published: (2014-12-01)

Arterial Stiffness Use for Early Monitoring of Cardiovascular Adverse Events due to Anthracycline Chemotherapy in Breast Cancer Patients. A Pilot Study
by: Cláudio Antônio de Souza, et al.
Published: (2018-09-01)

Effect of palonosetron, ondansetron and dexamethasone in the prevention of postoperative nausea and vomiting in video cholecystectomy with total venous anesthesia with propofol-remifentanil – randomized clinical trial
by: Neuber Martins Fonseca, et al.
Published: (2020-09-01)

Sobre o BCG na Imunização Ativa Inespecífica em Cancerologia
by: José Rosemberg
Published: (2023-08-01)

A Perspetiva da Toxicologia Clínica Sobre a Utilização Terapêutica da Cannabis e dos Canabinoides
by: Ricardo Jorge Dinis-Oliveira
Published: (2019-02-01)

Trastuzumab-Related Cardiotoxicity in Adjuvant Setting: A Real-World Scenario
by: Sarita Shrivastva, et al.
Published: (2023-07-01)

Individualização Farmacocinética das Doses de 5-Fluoruracil no Câncer Colorretal
by: Carina Gomes Martins, et al.
Published: (2013-06-01)

Interventions for Preventing Cardiotoxicity in Breast Cancer Patients Receiving Trastuzumab: A Systemic Review and Bayesian Network Meta-Analysis
by: Xinyi Li, et al.
Published: (2021-08-01)

Risks of trastuzumab‐related cardiotoxicity in breast cancer patients in Taiwan
by: Wei‐Ting Chang, et al.
Published: (2021-12-01)

Safety of Continuing Trastuzumab Despite Mild Cardiotoxicity
by: Darryl P. Leong, MBBS, MPH, MBiostat, PhD, et al.
Published: (2019-09-01)

Biomarcadores na Avaliação de Pacientes Submetidos à Quimioterapia com Antraciclinas
by: Aurora Felice Castro Issa
Published: (2024-03-01)

Interação entre especialidades: miocardiopatia dilatada e neoplasia de mama HER2 positiva Interacción entre especialidades: miocardiopatía dilatada y neoplasia de mama HER2 positiva Interaction between specialties: dilated cardiomyopathy and HER2-positive breast Cancer
by: Solange Moraes Sanches, et al.
Published: (2010-01-01)

Antioxidant Protection against Trastuzumab Cardiotoxicity in Breast Cancer Therapy
by: Gabriel Méndez-Valdés, et al.
Published: (2023-02-01)

Complicações da Punção de Veia Profunda em um Hospital de Câncer
by: Eduardo Velasco, et al.
Published: (2023-08-01)

Effects of trastuzumab and trastuzumab emtansine on corrected QT interval and left ventricular ejection fraction in patients with metastatic (HER2+) breast cancer
by: Rea Levicki, et al.
Published: (2023-02-01)

Disfunción cardiaca subclínica en pacientes oncológicos: Reporte de un caso
by: Enrique Ruiz-Mori, et al.
Published: (2020-01-01)

LUGOL’S IODINE CHROMOENDOSCOPY VERSUS NARROW BAND IMAGE ENHANCED ENDOSCOPY FOR THE DETECTION OF ESOPHAGEAL CANCER IN PATIENTS WITH STENOSIS SECONDARY TO CAUSTIC/CORROSIVE AGENT INGESTION
by: Caterina Maria Pia Simoni PENNACHI, et al.
Published: (2017-05-01)

Mechanisms of trastuzumab induced cardiotoxicity – is exercise a potential treatment?
by: Holden Eaton, et al.
Published: (2023-04-01)

Tratamiento Neoadyuvante en cáncer de mama HER2 positivo. La era de la terapia dirigida
by: Verónica Hurtado Hurtado, et al.
Published: (2020-12-01)

Gliomas de Alto Grado del Adulto: Biología Molecular (Parte I)
by: Lenin Fabián Palacios Paredes, et al.
Published: (2020-12-01)

Chemotherapy-induced cardiotoxic effect in breast cancer patients treated with trastuzumab (Herceptin) by MRI
by: Mohamed Aboulfotouh Mourad, et al.
Published: (2023-12-01)

Trastuzumab-induced thrombocytopenia after eight cycles of trastuzumab treatment
by: Zhou Qiong, et al.
Published: (2020-07-01)

Fadiga em Mulheres com Câncer de Mama Submetidas à Radioterapia
by: Julyana Cândido Bahia, et al.
Published: (2019-10-01)

Efectividad de Trastuzumab en combinación con terapia sistémica en pacientes con cáncer de mama avanzados o metastásico HER2 positivos. Experiencia del Hospital México, Costa Rica
by: Juan P. Molina, et al.
Published: (2017-12-01)

Farmacogenética e Implicações Terapêuticas no Câncer de Mama
by: Diogo Nascimento Piranda, et al.
Published: (2013-09-01)

Cardioprotective Agents for the Primary Prevention of Trastuzumab-Associated Cardiotoxicity: A Systematic Review and Meta-Analysis
by: Kyriakos Goulas, et al.
Published: (2023-07-01)

Cardiotoxicidade por Trastuzumabe em Pacientes Portadores de Cancer de Mama
by: Aguinaldo Figueiredo Freitas Jr, et al.
Published: (2014-03-01)

Structural and Electrophysiological Changes in a Model of Cardiotoxicity Induced by Anthracycline Combined With Trastuzumab
by: Claudia Altomare, et al.
Published: (2021-04-01)

Cardiotoxicity: Importance of biomarkers
by: Kostadinović Jelena, et al.
Published: (2023-01-01)

The Effectiveness of Trastuzumab Combined with Sequential Chemotherapy for Metastatic Gastric Carcinoma with Overexpression of HER2
by: Omar Saavedra Santa Gadea, et al.
Published: (2017-07-01)

Efficacy and safety of short course adjuvant trastuzumab combination chemotherapy in breast cancer
by: Sachin S Hingmire, et al.
Published: (2017-01-01)

Como Tratar o Câncer da Mama e Suas Metástases Pelos Hormônios Sexuais?
by: Adayr Eiras de Araújo
Published: (2023-10-01)

Trastuzumab Cures Cancer and Disrupts the Practice of Cardiology∗
by: Richard M. Steingart, MD, et al.
Published: (2019-09-01)